Innovation

2 patent families — focus: Chemistry & metallurgy, Physics & computing; filing pace dormant. Cited 27 times.

Year	Filings
2012	1

Investor mix

6 investors on record; lead investors include Merck Global Health Innovation Fund, Aberdare Ventures, Bay City Capital, New Leaf Venture Partners.

Investor type	Count	Share
Venture capital	4	67%
Other / undisclosed	2	33%